Position Paper – Transparency Directive Revision
Affordable Medicines Europe strongly support an ambitious revision of the Transparency Directive. It is a key objective for our sector to bring more affordable medicines to healthcare sys-tems and patients across the EU. The current lack of transparency of medicines prices is one of the key obstacles to reach this objective. We therefore called for real transparency in prices of medicines.